Article
CoCas9 is a compact nuclease from the human microbiome for efficient and precise genome editing
24 Apr 2024
Abstract excerpt
The expansion of the CRISPR-Cas toolbox is highly needed to accelerate the development of therapies for genetic diseases. Here, through the interrogation of a massively expanded repository of metagenome-assembled genomes, mostly from human microbiomes, we uncover a large variety (n = 17,173) of type II CRISPR-Cas loci. Among these we identify CoCas9, a strongly active and high-fidelity nuclease with reduced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
